You are worth tens of billions before you come to the system?

October 10th, Thursday.

Lin Zitai returned to Shanghai from Xiangjiang to sit on the front line.

Financial Director Mok Wenzhi informed that as of five o'clock yesterday afternoon.

Bank of China’s US$400 billion, Dai-ichi Life and Mitsui’s US$350 billion, and Samsung Group’s US$250 billion have all been received.

"Novartis still had US$264.3 billion left before investing, and currently holds a total of US$1264.3 billion in funds."

Mo Wenzhi looked serious and proofread it carefully many times, and his voice was trembling when he spoke.

Tens of millions of dollars is a goal that many people cannot achieve in their lifetime, let alone hundreds of billions of dollars.

If converted into RMB, the total is 8724 billion. In the big A market, there are only 18 companies with a market value of one trillion yuan.

What's more, more than 800 billion is in cash.

Lin Zitai thought for a long time, with a look of reluctance on his face: "Transfer all the funds from BlackRock and State Street to them."

If possible, he doesn't want to deliver it so quickly. After all, there is a tough battle to be fought on Monday and they need a lot of money.

However, the contract clearly stipulates that only when the money is received can the shares be transferred smoothly. If the money is not received, it is just in name only.

Because both BlackRock and State Street are worried that Monday's fundraising battle will affect the value of the stocks they hold.

Although things seem to be going well now, it's because both parties need chips, so it's attracting much attention.

Once the fundraising battle comes to an end, Merck's stock price is bound to experience an exaggerated correction.

If Frazier wins in the end, the stock price will probably return to the average line and rise symbolically by a dozen points.

If Lin Zitai wins in the end, the stock price drop will be very exaggerated.

Because Lin Zitai wants to acquire two companies, he must buy back shares and reorganize assets.

If Lin Zitai were a white man, then the European and American markets would be infinitely optimistic about the restructuring plans of the two companies.

However, he is a native Chinese. When Kim was in office, he would call his name from time to time and criticize him for plundering the wealth of the American people.

The United States, a seemingly free and equal country, is actually not free and equal at all. Otherwise, the original Indians would not have been nearly slaughtered and finally raised in captivity.

Racism has always been there, we just didn't dare to express it.

BlackRock and State Street can transfer their shares of Merck at a premium of 40%-50%, which is already a mouthful.

Although they are somewhat interested in the ensuing fundraising battle, they are not very interested and will not invest too much money.

I just want to settle down as soon as possible, reap the benefits, and be a freeloader, and don’t want to take unnecessary risks.

Mo Wenzhi nodded and went back to proofread the bill.

The financial department of the entire group was mobilized and reviewed five times in total, and we were careful and careful again.

After all, it involves tens of billions of dollars in transactions, and if there is even the slightest flaw, he will spend the rest of his life in prison.

The next day, Mo Wenzhi took the financial statements and came to Lin Zitai's office again.

"BlackRock holds 4.5%, and we bought it at a premium of 50% to the market price, consuming a total of US$241.69 billion."

"State Street held 4.3%, and we bought it at a 40% premium to the market price, consuming a total of US$215.51 billion."

Mok Wenzhi reported on the work and finally said: "The total cost is 457.2 billion, and the available funds are currently 807.1 billion US dollars."

Looking at this string of numbers, Lin Zitai thought for a long time and called the investment manager Lu Feng and the group general manager Liu Xiaojun.

The core management of the group and Parks from across the ocean were summoned to explain the next arrangements.

Lin Zitai plans to subdivide it into three parts.

The first part is to prepare US$300 billion for fundraising, because the private placement of 6.375 million shares means that everyone can participate in this fundraising battle.

Just like the issuance of new shares, investors obtain additional shares by winning the lottery. The more funds invested in this part, the greater the probability of winning the lottery.

A total of 6.375 million new shares were added, the issue price of a single share reached US$105.3, and the total raised funds were US$671.28 billion.

Although it is only more than 60 billion, the market is concerned about this piece of meat. Even if they invest all their funds, they cannot wrap up the round.

Once subscribed, the funds will be frozen, so we will only take out US$300 billion and do not plan to use all of it in this regard.

Although Lin Zitai likes Stud, Stud must also consider the situation. If he wants to defeat the strong with the weak, and if he wants to get rich instantly, he can only do Stud.

But now the situation is four to six, and they clearly have the advantage. If they stud again, they will not be courageous, but stupid.

Lin Zitai paused and then said: "The second part of the fund is 250 billion U.S. dollars. If the number of winning tickets does not meet expectations, we will buy back in the secondary market."

I don’t know how much capital was involved that day. Investors and speculators were planning to take advantage of both parties’ efforts to raise funds. It would not be surprising even if the subscription funds exceeded one trillion U.S. dollars. And their expectation this time is no longer 33.4%, because there are competitors, and even if the number of shares held exceeds one-third of the total share capital, the other party may surpass them.

After all, now, if this battle for funding wants to end, there are only two ways.

Either one party runs out of ammunition and is unable to recover, or one party holds 50.1% of the shares.

Frazier bet almost everything, even his own family fortune on the card table, and it would be even harder for him to give up.

Lin Zitai would not give up. In order to get support from Bank of China, he mortgaged his shares in Novartis and Mojin.

After all, no matter how proud he is, he can't just open his mouth and let Bank of China invest US$400 billion unconditionally.

Although the government's support is support, the collateral they should provide cannot be less.

Prince Lin is just a nickname, not the real prince.

"The last 257.1 billion. As a backup fund, if the first two parts do not go smoothly, support will be provided at any time."

Everyone nodded and memorized the required items one by one, not daring to slack off at all.

"It's time to talk, now we have to go all out."

"This merger and acquisition case, you and I, are destined to go down in history, but I hope we are the protagonists."

Lin Zitai also showed a long-lost excitement on his face. For him, this should be the last battle in business.

The last time he went to New York, what impressed him most was not the narrow Wall Street, nor the freedom of capitalists...

It’s Musk, his private exhibition hall, and his wild ideas.

Lin Zitai envies Musk for being able to pursue what he likes and realize some ridiculous ideas.

So he decided that no matter whether he wins or loses this time, he will pursue the stars and the sea in his heart.

But he hopes to have a perfect ending.

Everyone nodded in unison, realizing that this time they would become the protagonists of the world and the center of public opinion.

After the meeting, Lin Zitai opened the door and found Deng Jiahao looking anxious and walking back and forth.

When he saw Lin Zitai, he said hurriedly: "Mr. Lin, Mr. Musk wants to see you."

"Musk, has he come to China?"

Lin Zitai was surprised.

Deng Jiahao looked strange: "Mr. Musk, you are in our reception room on the second floor now."

Under normal circumstances, visits between entrepreneurs generally require assistants from both parties to negotiate the time and location.

This way we can avoid the embarrassment of not being able to see anyone when we arrive. After all, leaders of large companies are very busy every day.

Just like Lin Zitai, he was in Shanghai the day before yesterday, in Xiangjiang yesterday, and is back in Shanghai today.

If the meeting time is not determined in advance, it is very likely that Lin Zitai will not be able to meet him when he comes to the company.

However, Musk just came over blankly. If the lobby manager hadn't informed them, they would have had no idea.

"What a weirdo." Lin Zitai laughed.

Deng Jiahao was speechless and couldn't help but glance at Lin Zitai. Their boss Lin didn't seem to be any better than Musk.

When I went to New York last month, Lin Zitai originally just wanted to visit Wall Street and feel the atmosphere, so he went to the headquarters of the Blackstone Group on a whim.

Fortunately, Steve was having a meeting upstairs at that time and asked his assistant to come over to receive him. Otherwise, he wouldn't be able to see anyone, and those hawkish media in Europe and the United States might not know how to write properly.

Not long after, Lin Zitai followed Deng Jiahao to the reception room on the second floor of the building.

Seeing Lin Zitai, Musk smiled like a flower and hurriedly took a few steps forward and gave him a warm hug: "I'm sorry, I just couldn't bear it and took the liberty of visiting."

Ever since that day when Bone told about the magic of the blue pill, an inexperienced person could skillfully operate a bionic hand.

Every time he thought of this incident, he had trouble sleeping every night, as his heart seemed to have ten thousand ants crawling around it.

Even knowing that Novartis's acquisition of Merck is in full swing, Lin Zitai should be very busy recently.

But he couldn't help it, and came to Shanghai alone in the name of inspecting the Tesla Gigafactory.

Musk wanted to experience the wonders of the blue pill for himself.

He wanted to know what kind of medicine could turn theoretical feasibility into practical feasibility. (End of chapter)